Global Lung Cancer Therapy Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: GC23BB5CC82CEN
QYResearch

Abstracts

This report focuses on the global Lung Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• GlaxoSmithKline
• Menarini
• Pfizer
• Roche
• Merck
• AstraZeneca
• Sanofi-Aventis
• Eli Lilly and Company
• Abbott
• Akebia Therapeutics
• Agennix AG

Market segment by Type, the product can be split into

• Radiation Therapy
• Chemotherapy
• Targeted Therapies
• Immunotherapy

Market segment by Application, split into

• Hospitals
• Clinics
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Lung Cancer Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Lung Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Lung Cancer Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lung Cancer Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Lung Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Radiation Therapy
  1.4.3 Chemotherapy
  1.4.4 Targeted Therapies
  1.4.5 Immunotherapy
1.5 Market by Application
  1.5.1 Global Lung Cancer Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Lung Cancer Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Lung Cancer Therapy Industry
    1.6.1.1 Lung Cancer Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Lung Cancer Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Lung Cancer Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Lung Cancer Therapy Market Perspective (2015-2026)
2.2 Lung Cancer Therapy Growth Trends by Regions
  2.2.1 Lung Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Lung Cancer Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Lung Cancer Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Lung Cancer Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Lung Cancer Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Lung Cancer Therapy Players by Market Size
  3.1.1 Global Top Lung Cancer Therapy Players by Revenue (2015-2020)
  3.1.2 Global Lung Cancer Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lung Cancer Therapy Market Concentration Ratio
  3.2.1 Global Lung Cancer Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapy Revenue in 2019
3.3 Lung Cancer Therapy Key Players Head office and Area Served
3.4 Key Players Lung Cancer Therapy Product Solution and Service
3.5 Date of Enter into Lung Cancer Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Lung Cancer Therapy Historic Market Size by Type (2015-2020)
4.2 Global Lung Cancer Therapy Forecasted Market Size by Type (2021-2026)

5 LUNG CANCER THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Lung Cancer Therapy Market Size by Application (2015-2020)
5.2 Global Lung Cancer Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Lung Cancer Therapy Market Size (2015-2020)
6.2 Lung Cancer Therapy Key Players in North America (2019-2020)
6.3 North America Lung Cancer Therapy Market Size by Type (2015-2020)
6.4 North America Lung Cancer Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Lung Cancer Therapy Market Size (2015-2020)
7.2 Lung Cancer Therapy Key Players in Europe (2019-2020)
7.3 Europe Lung Cancer Therapy Market Size by Type (2015-2020)
7.4 Europe Lung Cancer Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Lung Cancer Therapy Market Size (2015-2020)
8.2 Lung Cancer Therapy Key Players in China (2019-2020)
8.3 China Lung Cancer Therapy Market Size by Type (2015-2020)
8.4 China Lung Cancer Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Lung Cancer Therapy Market Size (2015-2020)
9.2 Lung Cancer Therapy Key Players in Japan (2019-2020)
9.3 Japan Lung Cancer Therapy Market Size by Type (2015-2020)
9.4 Japan Lung Cancer Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Lung Cancer Therapy Market Size (2015-2020)
10.2 Lung Cancer Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lung Cancer Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Lung Cancer Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Lung Cancer Therapy Market Size (2015-2020)
11.2 Lung Cancer Therapy Key Players in India (2019-2020)
11.3 India Lung Cancer Therapy Market Size by Type (2015-2020)
11.4 India Lung Cancer Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Lung Cancer Therapy Market Size (2015-2020)
12.2 Lung Cancer Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Lung Cancer Therapy Market Size by Type (2015-2020)
12.4 Central & South America Lung Cancer Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Details
  13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.1.3 GlaxoSmithKline Lung Cancer Therapy Introduction
  13.1.4 GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2015-2020))
  13.1.5 GlaxoSmithKline Recent Development
13.2 Menarini
  13.2.1 Menarini Company Details
  13.2.2 Menarini Business Overview and Its Total Revenue
  13.2.3 Menarini Lung Cancer Therapy Introduction
  13.2.4 Menarini Revenue in Lung Cancer Therapy Business (2015-2020)
  13.2.5 Menarini Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Lung Cancer Therapy Introduction
  13.3.4 Pfizer Revenue in Lung Cancer Therapy Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Roche
  13.4.1 Roche Company Details
  13.4.2 Roche Business Overview and Its Total Revenue
  13.4.3 Roche Lung Cancer Therapy Introduction
  13.4.4 Roche Revenue in Lung Cancer Therapy Business (2015-2020)
  13.4.5 Roche Recent Development
13.5 Merck
  13.5.1 Merck Company Details
  13.5.2 Merck Business Overview and Its Total Revenue
  13.5.3 Merck Lung Cancer Therapy Introduction
  13.5.4 Merck Revenue in Lung Cancer Therapy Business (2015-2020)
  13.5.5 Merck Recent Development
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Details
  13.6.2 AstraZeneca Business Overview and Its Total Revenue
  13.6.3 AstraZeneca Lung Cancer Therapy Introduction
  13.6.4 AstraZeneca Revenue in Lung Cancer Therapy Business (2015-2020)
  13.6.5 AstraZeneca Recent Development
13.7 Sanofi-Aventis
  13.7.1 Sanofi-Aventis Company Details
  13.7.2 Sanofi-Aventis Business Overview and Its Total Revenue
  13.7.3 Sanofi-Aventis Lung Cancer Therapy Introduction
  13.7.4 Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2015-2020)
  13.7.5 Sanofi-Aventis Recent Development
13.8 Eli Lilly and Company
  13.8.1 Eli Lilly and Company Company Details
  13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.8.3 Eli Lilly and Company Lung Cancer Therapy Introduction
  13.8.4 Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2015-2020)
  13.8.5 Eli Lilly and Company Recent Development
13.9 Abbott
  13.9.1 Abbott Company Details
  13.9.2 Abbott Business Overview and Its Total Revenue
  13.9.3 Abbott Lung Cancer Therapy Introduction
  13.9.4 Abbott Revenue in Lung Cancer Therapy Business (2015-2020)
  13.9.5 Abbott Recent Development
13.10 Akebia Therapeutics
  13.10.1 Akebia Therapeutics Company Details
  13.10.2 Akebia Therapeutics Business Overview and Its Total Revenue
  13.10.3 Akebia Therapeutics Lung Cancer Therapy Introduction
  13.10.4 Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2015-2020)
  13.10.5 Akebia Therapeutics Recent Development
13.11 Agennix AG
  10.11.1 Agennix AG Company Details
  10.11.2 Agennix AG Business Overview and Its Total Revenue
  10.11.3 Agennix AG Lung Cancer Therapy Introduction
  10.11.4 Agennix AG Revenue in Lung Cancer Therapy Business (2015-2020)
  10.11.5 Agennix AG Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Lung Cancer Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Lung Cancer Therapy Revenue
Table 3. Ranking of Global Top Lung Cancer Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lung Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiation Therapy
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Targeted Therapies
Table 8. Key Players of Immunotherapy
Table 9. COVID-19 Impact Global Market: (Four Lung Cancer Therapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Lung Cancer Therapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Lung Cancer Therapy Players to Combat Covid-19 Impact
Table 14. Global Lung Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Lung Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Lung Cancer Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Lung Cancer Therapy Market Share by Regions (2015-2020)
Table 18. Global Lung Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Lung Cancer Therapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Lung Cancer Therapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Lung Cancer Therapy Players
Table 25. Global Lung Cancer Therapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Lung Cancer Therapy Market Share by Players (2015-2020)
Table 27. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapy as of 2019)
Table 28. Global Lung Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Lung Cancer Therapy Product Solution and Service
Table 31. Date of Enter into Lung Cancer Therapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 34. Global Lung Cancer Therapy Market Size Share by Type (2015-2020)
Table 35. Global Lung Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 36. Global Lung Cancer Therapy Market Size Share by Application (2015-2020)
Table 37. Global Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Lung Cancer Therapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Lung Cancer Therapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Lung Cancer Therapy Market Share (2019-2020)
Table 41. North America Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 42. North America Lung Cancer Therapy Market Share by Type (2015-2020)
Table 43. North America Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Lung Cancer Therapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Lung Cancer Therapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Lung Cancer Therapy Market Share (2019-2020)
Table 47. Europe Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Lung Cancer Therapy Market Share by Type (2015-2020)
Table 49. Europe Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Lung Cancer Therapy Market Share by Application (2015-2020)
Table 51. China Key Players Lung Cancer Therapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Lung Cancer Therapy Market Share (2019-2020)
Table 53. China Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 54. China Lung Cancer Therapy Market Share by Type (2015-2020)
Table 55. China Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Lung Cancer Therapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Lung Cancer Therapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Lung Cancer Therapy Market Share (2019-2020)
Table 59. Japan Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Lung Cancer Therapy Market Share by Type (2015-2020)
Table 61. Japan Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Lung Cancer Therapy Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Lung Cancer Therapy Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Lung Cancer Therapy Market Share (2019-2020)
Table 65. Southeast Asia Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Lung Cancer Therapy Market Share by Type (2015-2020)
Table 67. Southeast Asia Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Lung Cancer Therapy Market Share by Application (2015-2020)
Table 69. India Key Players Lung Cancer Therapy Revenue (2019-2020) (Million US$)
Table 70. India Key Players Lung Cancer Therapy Market Share (2019-2020)
Table 71. India Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 72. India Lung Cancer Therapy Market Share by Type (2015-2020)
Table 73. India Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 74. India Lung Cancer Therapy Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Lung Cancer Therapy Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Lung Cancer Therapy Market Share (2019-2020)
Table 77. Central & South America Lung Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Lung Cancer Therapy Market Share by Type (2015-2020)
Table 79. Central & South America Lung Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Lung Cancer Therapy Market Share by Application (2015-2020)
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 85. GlaxoSmithKline Recent Development
Table 86. Menarini Company Details
Table 87. Menarini Business Overview
Table 88. Menarini Product
Table 89. Menarini Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 90. Menarini Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Product
Table 104. Merck Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 105. Merck Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Product
Table 109. AstraZeneca Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 110. AstraZeneca Recent Development
Table 111. Sanofi-Aventis Company Details
Table 112. Sanofi-Aventis Business Overview
Table 113. Sanofi-Aventis Product
Table 114. Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 115. Sanofi-Aventis Recent Development
Table 116. Eli Lilly and Company Business Overview
Table 117. Eli Lilly and Company Product
Table 118. Eli Lilly and Company Company Details
Table 119. Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 120. Eli Lilly and Company Recent Development
Table 121. Abbott Company Details
Table 122. Abbott Business Overview
Table 123. Abbott Product
Table 124. Abbott Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 125. Abbott Recent Development
Table 126. Akebia Therapeutics Company Details
Table 127. Akebia Therapeutics Business Overview
Table 128. Akebia Therapeutics Product
Table 129. Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 130. Akebia Therapeutics Recent Development
Table 131. Agennix AG Company Details
Table 132. Agennix AG Business Overview
Table 133. Agennix AG Product
Table 134. Agennix AG Revenue in Lung Cancer Therapy Business (2015-2020) (Million US$)
Table 135. Agennix AG Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Lung Cancer Therapy Market Share by Type: 2020 VS 2026
Figure 2. Radiation Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapies Features
Figure 5. Immunotherapy Features
Figure 6. Global Lung Cancer Therapy Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Lung Cancer Therapy Report Years Considered
Figure 11. Global Lung Cancer Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Lung Cancer Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Lung Cancer Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Lung Cancer Therapy Market Share by Players in 2019
Figure 16. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2019
Figure 18. North America Lung Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Lung Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Lung Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Lung Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Lung Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Lung Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Lung Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 27. Menarini Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Menarini Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 31. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Roche Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 33. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Merck Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 35. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AstraZeneca Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 37. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sanofi-Aventis Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 39. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 41. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Abbott Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 43. Akebia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Akebia Therapeutics Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 45. Agennix AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Agennix AG Revenue Growth Rate in Lung Cancer Therapy Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed